Jerome Nollet WG85 offers a plan for distributing corporate shares to employees in an effort to reduce economic inequality and address current criticisms of capitalism.
Changes to Communications Decency Act are needed to protect cybercrime victims.
Experts from Wharton Customer Analytics weigh in on what's ahead for this rapidly-growing technology.
Finding silver linings of work life during the current crisis could reinvigorate teams when they return to the office, writes Nancy Davis Kho W88, author of The Thank-You Project.
Wharton authors share expertise on negotiation strategies, cultivating happiness, secrets to startup success, and more.
The coronavirus is spurring new applications and developments for the technology within the sector.
A contract is not necessarily a promise, says Maurice Lefkort W86
The Federal Reserve should encourage banks to manage their own risk and incentivize lending, says the senior director of the Harris Alternative Investments Program.
Robertson reflects on adapting to COVID-19, reactions and actions sparked by Black Lives Matter, how alumni can best help students, and her priorities for the upcoming fall semester.
Amy Howe WG99, head of Ticketmaster North America, on adapting to COVID-19 realities, new live entertainment technology, and advice that has shaped her career.
Wharton management professor Stephanie Creary offers advice for penning a substantive public statement and stresses the importance of walking the talk.
Videos and readings from professor Mauro Guillén’s popular COVID-19 class provide insights on managing global business in uncertain times.
Staff vacancies and the inability to grow add stress in already difficult times. But professor Matthew Bidwell sees opportunity in crisis.
Dean Geoffrey Garrett argues that we must consider the long-term implications of these trends as the tide turns toward them.
Wharton's Executive MBA career director says lessons learned during the coronavirus pandemic will be critical to your long-term professional health.
Wharton Customer Analytics experts explore the art and science of risk management as it applies to global food security, both today and post-coronavirus.
The industry’s investors often are portrayed as greedy corporate raiders, but a new study argues the opposite may be true.
With institutional investors cautious and public markets volatile, the author says fintech is the answer.
This season's alumni books include a wide range of topics—from an analysis of private equity to a look into fashion supply chain management and globalization in the Trump era.
In her latest “Perfect Pitch” column, Katlyn Grasso W15 discusses leadership and increasing gender diversity on the cap table with Beth Ferreira, managing partner of WME Ventures.
Anticipating the impacts of social unrest is increasingly critical for investors.
From Wharton Leadership Ventures to lessons in the classroom, one alumnus reflects on how the skills he learned at Wharton have helped him throughout his career, particularly with his newest venture, Chronus.
Startup accelerators sound awesome, right? They can be, but entrepreneurs should still be aware of these six pros and cons before joining one.
In the world of finance, the more investors know about an asset, the greater their competitive advantage. Data science has taken this relationship to new levels in private equity.
We spotlight cities that have hot startup scenes and Wharton alumni involvement.
Permanent capital structures are an opportunity that eliminates many of private equity’s drawbacks for investors.
New Wharton research indicates that individuals’ investment decisions may outperform those of their venture capital firm. What's the power of gut feel?
A group of alumni apply research by Wharton professors Peter Fader and Eric Bradlow to bring data science to investing.
A dose of business principles, in large part from venture philanthropy, is changing the way medical research is done in the U.S. health care industry.
Two alumnae launch into rarefied air with their own female-led venture capital fund for startups healing heath care with digital technology.
Can you steer your new company away from these seven icebergs (aka common startup mistakes)? Peter Cohan helps to chart a course.
Increasingly, biotech startups are turning to corporate venture capital and crowdfunding for funding. How do these alternative sources of money affect their outcomes though?